Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.

Autor: Vylegzhanina AV; Genome Protection, Inc., Buffalo, New York., Bespalov IA; Genome Protection, Inc., Buffalo, New York., Novototskaya-Vlasova KA; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Hall BM; Genome Protection, Inc., Buffalo, New York., Gleiberman AS; Genome Protection, Inc., Buffalo, New York., Yu H; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Leontieva OV; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Leonova KI; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Kurnasov OV; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California., Osterman AL; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California., Dy GK; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Komissarov AA; I.V. Davydovsky Clinical City Hospital, Moscow, Russia.; A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia., Vasilieva E; I.V. Davydovsky Clinical City Hospital, Moscow, Russia.; A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia., Gehlhausen J; Yale University, New Haven, Connecticut., Iwasaki A; Yale University, New Haven, Connecticut.; Howard Hughes Medical Institute, Chevy Chase, Maryland., Ambrosone CB; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Tsuji T; University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois., Matsuzaki J; University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois., Odunsi K; University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois., Andrianova EL; Genome Protection, Inc., Buffalo, New York., Gudkov AV; Genome Protection, Inc., Buffalo, New York.; Roswell Park Comprehensive Cancer Center, Buffalo, New York.

Publikováno v: Cancer research communications [Cancer Res Commun] 2023 Nov 08; Vol. 3 (11), pp. 2256-2267.

Development of infrastructure for a systemic multidisciplinary approach to study aging in retired sled dogs.

Autor: Fleyshman DI; Vaika, Inc., East Aurora, NY 14052, USA., Wakshlag JJ; Cornell University College of Veterinary Medicine, Ithaca, NY 14853, USA., Huson HJ; Cornell University College of Agriculture and Life Sciences, Ithaca, NY 14853, USA., Loftus JP; Cornell University College of Veterinary Medicine, Ithaca, NY 14853, USA., Olby NJ; North Carolina State University College of Veterinary Medicine, Raleigh, NC 27606, USA., Brodsky L; Tauber Bioinformatic Research Center, University of Haifa, Haifa, Israel., Gudkov AV; Vaika, Inc., East Aurora, NY 14052, USA.; Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Andrianova EL; Vaika, Inc., East Aurora, NY 14052, USA.

Publikováno v: Aging [Aging (Albany NY)] 2021 Sep 28; Vol. 13 (18), pp. 21814-21837. Date of Electronic Publication: 2021 Sep 28.

OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis.

Autor: Korotchkina L; Oncotartis, Inc., Buffalo, NY, USA., Kazyulkin D; Oncotartis, Inc., Buffalo, NY, USA., Komarov PG; Oncotartis, Inc., Buffalo, NY, USA., Polinsky A; Oncotartis, Inc., Buffalo, NY, USA., Andrianova EL; Oncotartis, Inc., Buffalo, NY, USA., Joshi S; Oncotartis, Inc., Buffalo, NY, USA., Gupta M; Oncotartis, Inc., Buffalo, NY, USA., Vujcic S; Oncotartis, Inc., Buffalo, NY, USA., Kononov E; Oncotartis, Inc., Buffalo, NY, USA., Toshkov I; Oncotartis, Inc., Buffalo, NY, USA., Tian Y; Oncotartis, Inc., Buffalo, NY, USA., Krasnov P; Oncotartis, Inc., Buffalo, NY, USA., Chernov MV; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Veith J; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Antoch MP; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Middlemiss S; Children's Cancer Institute, Sydney, NSW, Australia., Somers K; Children's Cancer Institute, Sydney, NSW, Australia., Lock RB; Children's Cancer Institute, Sydney, NSW, Australia., Norris MD; Children's Cancer Institute, Sydney, NSW, Australia.; University of New South Wales Centre for Childhood Cancer Research, Sydney, NSW, Australia., Henderson MJ; Children's Cancer Institute, Sydney, NSW, Australia., Haber M; Children's Cancer Institute, Sydney, NSW, Australia., Chernova OB; Oncotartis, Inc., Buffalo, NY, USA., Gudkov AV; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. andrei.gudkov@roswellpark.org.

Publikováno v: Leukemia [Leukemia] 2020 Jul; Vol. 34 (7), pp. 1828-1839. Date of Electronic Publication: 2020 Jan 02.

Genotoxicity of two new carbazole derivatives with antifungal activity.

Autor: Zhanataev AK; Zakusov Research Institute of Pharmacology, 8 Baltiyskaya St., Moscow, 125315, Russia., Eremina NV; Zakusov Research Institute of Pharmacology, 8 Baltiyskaya St., Moscow, 125315, Russia; Panacela Labs LLC, 12,Blvd.1, Krivokolennyi Per., Moscow, 101000, Russia. Electronic address: neremina@panacelalabs.com., Chayka ZV; Zakusov Research Institute of Pharmacology, 8 Baltiyskaya St., Moscow, 125315, Russia., Kazey VI; Panacela Labs LLC, 12,Blvd.1, Krivokolennyi Per., Moscow, 101000, Russia., Andrianova EL; Panacela Labs LLC, 12,Blvd.1, Krivokolennyi Per., Moscow, 101000, Russia., Purmal AA; Сleveland BioLabs, Inc., 73 High St., Buffalo, NY, 14203, USA., Rydkina EB; Сleveland BioLabs, Inc., 73 High St., Buffalo, NY, 14203, USA., Durnev AD; Zakusov Research Institute of Pharmacology, 8 Baltiyskaya St., Moscow, 125315, Russia.

Publikováno v: Mutation research. Genetic toxicology and environmental mutagenesis [Mutat Res Genet Toxicol Environ Mutagen] 2017 Apr; Vol. 816-817, pp. 24-31. Date of Electronic Publication: 2017 Apr 01.

Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma.

Autor: Wang, Qiangsheng¹ (AUTHOR), Shi, Qiqin² (AUTHOR), Wang, Zhenqian³ (AUTHOR), Lu, Jiawen³ (AUTHOR), Hou, Jian⁴ (AUTHOR) houjian@medmail.com.cn

Publikováno v: BMC Medicine. 9/29/2023, Vol. 21 Issue 1, p1-13. 13p.